165 related articles for article (PubMed ID: 12017227)
1. Autoantibodies in children with type 2 diabetes mellitus.
Umpaichitra V; Banerji MA; Castells S
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
[TBL] [Abstract][Full Text] [Related]
2. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
3. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
5. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
[TBL] [Abstract][Full Text] [Related]
11. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
12. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
[TBL] [Abstract][Full Text] [Related]
13. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients].
Zhang C; Zhou ZG; Lin J; Huang G; Wang JP; Zhang DM; Zhou M; Yang XL
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):797-801. PubMed ID: 18756979
[TBL] [Abstract][Full Text] [Related]
14. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B; Galloway TS; Wilkin TJ
Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
[TBL] [Abstract][Full Text] [Related]
15. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
Perusicová J; Bárová H; Hill M; Masek Z
Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
17. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
19. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
